KDIGO
KDIGO
  • 197
  • 399 227
KDIGO 2024 Guideline on Lupus Nephritis (LN): A Roundtable Discussion
This is a recording of the session "KDIGO 2024 Guideline on Lupus Nephritis (LN): A Roundtable Discussion" from the 2024 ERA Congress in Stockholm, Sweden.
The session was co-chaired by KDIGO LN Guideline Co-Chair Brad Rovin, MD (United States) and LN Guideline Work Group Member Vladimir Tesar, MD (Czechia), with presentations by LN Guideline Work Group Members Juan Manuel Mejía Vilet, MD (Mexico) and Isabelle Ayoub, MD (United States). The session also features a patient perspective on living with lupus by Jeanette Andersen (Denmark).
The session was supported by Roche.
zhlédnutí: 1 018

Video

KDIGO Scientific Symposium on the Impact of Viral Infection and the Role of Vaccines in Kidney Care
zhlédnutí 434Před dnem
This is a recording of the KDIGO scientific symposium, "The Impact of Viral Infections in Patients with Renal Diseases and the Role of Vaccination in Kidney Care," which was held at the 61st ERA Congress in Stockholm, Sweden, in May 2024. The symposium was chaired by Steven Chadban, MD (Australia), with speakers Uyen Huynh-Do, MD (China), Michel Jadoul, MD (Belgium), and Deepali Kumar, MD (Cana...
KDIGO Heart Failure & Kidney Disease Conference Plenary: Patient Panel
zhlédnutí 226Před 14 dny
This is a recording of the patient panel plenary presentation from the KDIGO 2024 Controversies Conference on Kidney Disease and Heart Failure: Recent Advances and Current Challenges. The conference was held in Vancouver, Canada, in March 2024. Dr. Nisha Bansal (University of Washington, United States) and Dr. Carolyn Lam (National Heart Centre Singapore and Duke-National University of Singapor...
KDIGO Heart Failure & CKD Conference Plenary: Prediction of Heart Failure in Patients with CKD
zhlédnutí 295Před 14 dny
This is a recording of "Prediction of Heart Failure in Patients with CKD," a plenary presentation by Dr. Josef Coresh (Optimal Aging Institute and NYU Grossman School of Medicine, United States) from the KDIGO 2024 Controversies Conference on Kidney Disease and Heart Failure: Recent Advances and Current Challenges. The conference was held in Vancouver, Canada, in March 2024. Dr. Nisha Bansal (U...
KDIGO Heart Failure & Kidney Disease Conference Plenary: Interdisciplinary Care Models
zhlédnutí 155Před 14 dny
This is a recording of "Interdisciplinary Care Models: Implementation Strategies to Address Global Unmet Needs," a plenary presentation by Dr. Elke Eaton (University Hospitals Cleveland, United States), Dr. Debasish Banerjee (St George's University Hospitals NHS Foundation Trust, United Kingdom), and Dr. Lisa Anderson (St George's Hospital London, United Kingdom) from the KDIGO 2024 Controversi...
KDIGO Heart Failure & Kidney Disease Conference Plenary: A New Era of GDMT
zhlédnutí 851Před 14 dny
This is a recording of "A New Era of GDMT: Are We Witnessing a Convergence of GDMT for Heart Failure and CKD?," a plenary presentation by Dr. Brendon Neuen (Royal North Shore Hospital and The George Institute for Global Health, Australia) from the KDIGO 2024 Controversies Conference on Kidney Disease and Heart Failure: Recent Advances and Current Challenges. The conference was held in Vancouver...
KDIGO Heart Failure & Kidney Disease Conference Plenary: New AHA CKM Staging
zhlédnutí 316Před 21 dnem
This is a recording of "New AHA Cardiovascular-Kidney-Metabolic (CKM) Staging Solves All Our Staging Problems and Should Be Applied Universally: A Cardiology and Nephrology Perspective," a plenary session presentation by Dr. Robert Mentz (Duke University, United States) and Dr. Adeera Levin (University of British Columbia St Paul's Hospital, Canada) from the KDIGO 2024 Controversies Conference ...
KDIGO 2024 Guideline for Chronic Kidney Disease: Key Messages for Primary Care Physicians
zhlédnutí 667Před 28 dny
In this video, Dr. Xavier Cos (Spain) shares crucial insights and key messages for primary care physicians about the timely diagnosis of chronic kidney disease (CKD) and prompt initiation of its treatment. Specifically, Dr. Cos highlights the importance of early detection of CKD and the means for its proper staging and risk stratification. Most importantly, Dr. Cos details the medical approache...
KDIGO 2024 ANCA Vasculitis Guideline: Reading Between the Lines
zhlédnutí 1,2KPřed měsícem
In this webinar, KDIGO 2024 ANCA Vasculitis Guideline Co-Chair Brad Rovin, MD (United States), and Geetha Duvuru, MD (United States) review the latest KDIGO guidance using case-based studies, including a discussion on indications for plasma exchange and avacopan, to showcase challenging patient scenarios and illustrate the optimal application of guideline recommendations and practice points. To...
61st ERA Congress Highlights on Complement-Mediated Kidney Disease with Marina Vivarelli
zhlédnutí 426Před měsícem
In this video, Marina Vivarelli, MD (Italy), shares highlights on complement-mediated kidney disease from the 61st ERA Congress, which took place in Stockholm, Sweden, from May 23 to 26, 2024. Dr. Vivarelli co-chaired the KDIGO Controversies Conference on the Role of Complement in Kidney Disease in 2022 and was a Work Group Member on the KDIGO 2021 Guideline for the Management of Glomerular Dis...
61st ERA Congress Highlights on IgA Nephropathy with Jonathan Barratt
zhlédnutí 435Před měsícem
In this video, Professor Jonathan Barratt, MD (United Kingdom), shares highlights in IgA Nephropathy (IgAN) from the 61st ERA Congress, which took place in Stockholm, Sweden, from May 23 to 26, 2024. Dr. Barratt was a Work Group Member on the KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases and is a Work Group Member on the upcoming KDIGO IgAN Guideline. This vid...
A Contemporary Approach to Treatment of Anemia for Dialysis Patients: A KDIGO Perspective
zhlédnutí 785Před měsícem
This is a recording of "A Contemporary Approach to Treatment of Anemia for Dialysis Patients: A KDIGO Perspective" from the 2024 American Nephrology Nurses Association (ANNA) National Symposium in Orlando, Florida. In this session, an expert panel of nurses and clinicians discuss recent advances in the treatment of anemia in patients on dialysis. Speakers include: Lillian A. Pryor MSN, RN, CNN ...
Expert Roundtable Discussion on Dialysis-Related Amyloidosis (DRA)
zhlédnutí 310Před měsícem
According to the recent KDIGO Controversies Conference on Symptom-Based Complications in Dialysis, the symptom burden is high in patients undergoing hemodialysis therapy, with as many as 30 different kinds of symptoms having been reported. Although patients can experience an average of 9 symptoms, routine symptom assessment is not universal or standardized in dialysis care. Particularly, patien...
Dialysis-Related Amyloidosis (DRA): We Still Have a Long Way to Go
zhlédnutí 214Před měsícem
According to the recent KDIGO Controversies Conference on Symptom-Based Complications in Dialysis, the symptom burden is high in patients undergoing hemodialysis therapy, with as many as 30 different kinds of symptoms having been reported. Although patients can experience an average of 9 symptoms, routine symptom assessment is not universal or standardized in dialysis care. Particularly, patien...
Dialysis-Related Amyloidosis: A Perspective from the US
zhlédnutí 269Před měsícem
According to the recent KDIGO Controversies Conference on Symptom-Based Complications in Dialysis, the symptom burden is high in patients undergoing hemodialysis therapy, with as many as 30 different kinds of symptoms having been reported. Although patients can experience an average of 9 symptoms, routine symptom assessment is not universal or standardized in dialysis care. Particularly, patien...
Pathophysiology of Dialysis-Related Amyloidosis: B2-Microglobulin-Related Amyloid Fibril Formation
zhlédnutí 316Před měsícem
Pathophysiology of Dialysis-Related Amyloidosis: B2-Microglobulin-Related Amyloid Fibril Formation
KDIGO 2024 Guideline on ANCA-Associated Vasculitis: Update on Current Management and Treatment
zhlédnutí 2,5KPřed měsícem
KDIGO 2024 Guideline on ANCA-Associated Vasculitis: Update on Current Management and Treatment
Part 2: An Expert Approach to Cardiorenal Protection in CKD
zhlédnutí 637Před měsícem
Part 2: An Expert Approach to Cardiorenal Protection in CKD
Part 1: An Expert Approach to Cardiorenal Protection in CKD
zhlédnutí 913Před měsícem
Part 1: An Expert Approach to Cardiorenal Protection in CKD
Optimising RAASi Management in Cardiorenal Patients
zhlédnutí 628Před měsícem
Optimising RAASi Management in Cardiorenal Patients
Personalizing Our Approach: A Focus on Targeting Diabetes with Concomitant CKD
zhlédnutí 527Před měsícem
Personalizing Our Approach: A Focus on Targeting Diabetes with Concomitant CKD
Personalizing Our Approach: A Focus on the Diagnosis and Prognosis of CKD
zhlédnutí 574Před měsícem
Personalizing Our Approach: A Focus on the Diagnosis and Prognosis of CKD
Leaving No Stone Unturned: Optimizing Management for Patients with CKD
zhlédnutí 1,6KPřed 2 měsíci
Leaving No Stone Unturned: Optimizing Management for Patients with CKD
Tailored Care: A Push Towards Personalization in the Diagnosis and Prognosis of CKD
zhlédnutí 1,4KPřed 2 měsíci
Tailored Care: A Push Towards Personalization in the Diagnosis and Prognosis of CKD
(Subtítulos en Español) KDIGO 2024 CKD Guideline Top 10 Takeaways for Nephrologists: Evaluación
zhlédnutí 341Před 2 měsíci
(Subtítulos en Español) KDIGO 2024 CKD Guideline Top 10 Takeaways for Nephrologists: Evaluación
KDIGO 2024 CKD Guideline Top 10 Takeaways for Nephrologists: Evaluation
zhlédnutí 1,3KPřed 2 měsíci
KDIGO 2024 CKD Guideline Top 10 Takeaways for Nephrologists: Evaluation
(Subtítulos en Español) KDIGO 2024 CKD Guideline Top 10 Takeaways for Nephrologists: Gestión
zhlédnutí 730Před 2 měsíci
(Subtítulos en Español) KDIGO 2024 CKD Guideline Top 10 Takeaways for Nephrologists: Gestión
KDIGO 2024 CKD Guideline Top 10 Takeaways for Nephrologists: Management
zhlédnutí 1,8KPřed 2 měsíci
KDIGO 2024 CKD Guideline Top 10 Takeaways for Nephrologists: Management
Part 6 - Primary Care Insights from the KDIGO CKD Guideline: SLG2 Inhibitors
zhlédnutí 1,1KPřed 3 měsíci
Part 6 - Primary Care Insights from the KDIGO CKD Guideline: SLG2 Inhibitors
Part 5 - Primary Care Insights from the KDIGO CKD Guideline: Statins, BP Control & RAS Inhibitors
zhlédnutí 928Před 3 měsíci
Part 5 - Primary Care Insights from the KDIGO CKD Guideline: Statins, BP Control & RAS Inhibitors

Komentáře

  • @Koronajewell
    @Koronajewell Před 8 dny

    I'm a dialysis patient in the US. I take fish oils every morning before dialysis instead of using heparin as a blood thinner. The one day I forgot to take my fish oil, the dialysis machine clotted up. Fish oil does work for me.

  • @Dr_Sri_Harsha_Guthikonda

    Certainly! Based on the video transcript, here are the chapters for the video: **Chapter 1: Introduction to IGA Nephropathy and FSGS Webinar** [00:00:05][^1^][1] - Greetings and welcome - Overview of the webinar series - Introduction of speakers **Chapter 2: Diagnosing IGA Nephropathy** [00:01:17][^2^][2] - Pathology basis for diagnosis - Characteristics of IGA Nephropathy - Differential diagnosis and distinguishing factors **Chapter 3: Pathophysiology and Clinical Aspects of IGA Nephropathy** [00:13:22][^3^][3] - Historical perspective of IGA Nephropathy - Clinical trials and targeting pathways - Importance of blood pressure control and lifestyle modifications **Chapter 4: Biopsy Predictors and Stratification** [00:07:24][^4^][4] - The role of renal biopsy in diagnosis and prognosis - International consensus on classification - The Oxford approach to classification **Chapter 5: Clinical Implications of Biopsy Findings** [00:42:42][^5^][5] - The significance of crescents in IGA Nephropathy - The importance of clinical context in treatment decisions **Chapter 6: Lifestyle Modifications and Patient Management** [00:32:23][^6^][6] - Supportive therapy approaches - The impact of diet, obesity, and smoking on IGA Nephropathy - Recommendations for physical activity **Chapter 7: Conclusion and Q&A Session** [00:47:13][^7^][7] - Summary of key points from the webinar - Audience questions and expert responses - Closing remarks and future webinars These chapters provide a structured overview of the video's content, making it easier to navigate through the different topics discussed. If you need more detailed information or specific time stamps for each chapter, feel free to ask!

  • @bondardmytro2783
    @bondardmytro2783 Před 9 dny

    What is MRST classification?

  • @darkeio
    @darkeio Před 11 dny

    thank you so much for your lecture

  • @kevinwellwrought2024
    @kevinwellwrought2024 Před 12 dny

    My protein 24 hour is over 1000. As long as I take cortisol it stays the same but whenever I stop it startd going over 1000. This proves that cortisols are just like painkillers and do not treat IGA and second IGA has no treatment and medical sciences are all defeated by it

  • @a.m.hherez3460
    @a.m.hherez3460 Před 19 dny

    Whats GDMT

    • @vietleuc913
      @vietleuc913 Před 18 dny

      Guideline-Directed Medical Therapy

  • @kleptocracyrulez763
    @kleptocracyrulez763 Před 20 dny

    Wonderful discussion...

  • @dipeesingh9242
    @dipeesingh9242 Před 21 dnem

    Does that mean weight lifting causes blood pressure to be raised to a level that it damages kidney irreversibly everytime? Very counter intuitive!!!

  • @drvishwaprakashtiwari1217

    Any suggestion regarding duration of maintance

  • @hamadaadl5637
    @hamadaadl5637 Před měsícem

    Thanks

  • @hamadaadl5637
    @hamadaadl5637 Před měsícem

    Thank you

  • @badrulmunir8042
    @badrulmunir8042 Před 2 měsíci

    Thank you for sharing

  • @conjeevaramkesavan5467
    @conjeevaramkesavan5467 Před 2 měsíci

    Excellent thoughts Several Major issues Lack of concern for humanity and no forethought Total inertia even in application of measures Big pharma driving business for pharmacotherapy using human Guinea pigs paying medical professionals Ruthless greed making cost of newer medicines absolutely unaffordable No one bothered about prevention and no effort made on implementing life style interventions aggressively in real world Great talk appreciate his insight forethought with total compassion and caring He needs to be rewarded

  • @jonathanbolanos3825
    @jonathanbolanos3825 Před 2 měsíci

    I'm confused. He said referral to nephrology when eGFR <30, yet the guideline says transition to nephrology care when eGFR<60.

  • @abifantaw
    @abifantaw Před 3 měsíci

    am internal medicine resident in ethiopia these lectures help me alot thanks

  • @ShilpaSharma-tf4of
    @ShilpaSharma-tf4of Před 3 měsíci

    Very Informative. We Can also use Mutrakrichantak churan of Planet Ayurveda, its a magic herb I must say.

  • @ahmedahm1
    @ahmedahm1 Před 5 měsíci

    34:50 The caveat is that ACEi/ARBs are effective in persons with albuminuria +/- DM (benefit in patients without albuminuria is less consistent)

  • @GloriaAynera
    @GloriaAynera Před 6 měsíci

    Thank you so much. I need to know more from this new guidelines. God bless to all kdigo group.

  • @Rene-uz3eb
    @Rene-uz3eb Před 6 měsíci

    4:12 actually the graph shows less than 30% are anemic (<10 g/dl) even in stage 5, and only 5% are anemic in stage 3a 9:47 The ferritin > 500 had the highest mortality at 1.38. I just looked up the paper. Only 'iron deficiency' at < 100 ferritin had NO increase in mortality. So mortality clearly increased with the level of iron, in the presenter's paper of choice. In her defense, the paper makes the same claims even though the data is right there. I'm not sure why anyone would pick hospitalization data (for which the p value was not even significant) when you have significant mortality data. 11:08 trial results irrelevant for non-dialysis patients 15:36 find-ckd results: "The increase in hepcidin from baseline was significantly smaller with low ferritin FCM or oral iron vs high ferritin FCM at all time points up to week 52." In other words, giving a lot of iron is counterproductive since it increases hepcidin and locks down all that extra iron (aka iron overload). Hepcidin levels more than doubled even in the 'low' iron arm. That being said, 16:05 shows that Hb does respond to adding more iron alone. The question is was it worth it (not according to mortality data, and guidelines not to try to raise Hb all the way to normal), when instead Hb could have been raised with ESA alone. The trial nad no mortality data. I think the trick with excess iron raising Hb is, the targeted, way too high, ferritin levels lead to spilling of Fe iron from the ferritin into the blood, which bypasses iron release by macrophages with ferroportin, ie bypasses hepcidin regulation. That's basically freeing iron by making the liver spill over. Which over time will also end up locked into other body cells by hepcidin. 17:45 the confirm-hf trial did allow anemic patients (no limit on low Hb). So obviously they would wind up with more blood and thus more oxygen to walk a few meters more. There was no benefit to mortality. 19:28 it is not clear if high fgf23 in late ckd worsens or improves the condition 36:04 storage level of vitamin D also strongly raises HIF in hypoxia ie in anemia. So raising D storage levels should work just as well as preventing breakdown of HIF with the drug Roxadustat (note it's the circulating storage form, not the active form of vit D, that potentiates HIF): Regulation of Hypoxia Inducible Factors HIF-1 and HIF-2 by Calcidiol in Hepatocellular Carcinoma Cells Under Normoxia and Hypoxia, 2022 40:20 first time I hear a nephrologist describe lower saturation and ferritin as an improvement. According to the 'guidelines', this improvement just made the patients iron deficient.

  • @lindarosita4268
    @lindarosita4268 Před 6 měsíci

    Thank you for sharing , so interesting

  • @mohiesaadi8544
    @mohiesaadi8544 Před 7 měsíci

    Well done 👍

  • @murderthedancefloor3
    @murderthedancefloor3 Před 9 měsíci

    I am curious to see if these clinical guidelines align with the VA's 2019 guidelines (approved for VA physicians) in addressing patient-centered care and shared decision-making- an area where the KDIGO 2012 guidelines are lacking. Very interested to see what's ahead.

  • @ohudyansary
    @ohudyansary Před 9 měsíci

    thanks a lot. how to get Kdigo 2023 guidelines?

    • @murderthedancefloor3
      @murderthedancefloor3 Před 9 měsíci

      Curious as well. This was uploaded in June and they say "in the coming weeks"; however, it is now October and the current guidelines are growing more and more outdated as the world has vastly changed (especially for CKD patients) since 2012.

    • @ernestflores5608
      @ernestflores5608 Před 8 měsíci

      Still not officially out yet, you can google KDIGO CKD Draft and can find a JULY 2023 PUBLIC REVIEW DRAFT.

  • @rebeccabins
    @rebeccabins Před 9 měsíci

    Promo'SM 🤷

  • @user-qg2bg1hq8n
    @user-qg2bg1hq8n Před 10 měsíci

    Great example of one person with kidney disease’s why they act to protect their health and be here for their family. Outstanding engagement.

  • @guillermodiazalonso8574
    @guillermodiazalonso8574 Před 11 měsíci

    Excelente

  • @seyifekibru4028
    @seyifekibru4028 Před 11 měsíci

    Thank you!

  • @adamualiyukukawa3748

    Words failed me on how to appreciate you for sending your Herbs to me after I place my or order which cured my Type 2 Diabetes Dr Igudia

  • @adamualiyukukawa3748

    Words failed me on how to appreciate you for sending your Herbs to me after I place my or order which cured my diabetes Dr Igudia

  • @maktaba4000
    @maktaba4000 Před rokem

    I like. Always some motivation is very important for patient to stay good for long time

  • @sravanivaka8614
    @sravanivaka8614 Před rokem

    thank you treated the patient with k 9.8 sucessfully

  • @trantuantu4906
    @trantuantu4906 Před rokem

    thank you for sharing!

  • @JimmyButler221
    @JimmyButler221 Před rokem

    From the very first I day came across Dr Igudia CZcams channel, I knew that was going to be the end of my Type 2 diabetes. And to my surprise his herbs actually cured my Diabetes.

  • @JimmyButler221
    @JimmyButler221 Před rokem

    From the very first I day came across Dr Igudia CZcams channel, I knew that was going to be the end of my Type 2 Diabetes. And to my surprise his herbs actually cured my Diabetes.

  • @JimmyButler221
    @JimmyButler221 Před rokem

    From the very first I day came across Dr Igudia CZcams channel, I knew that was going to be the end of my Type 2 Diabetes. And to my surprise his herbs actually cured my Diabetes

  • @JimmyButler221
    @JimmyButler221 Před rokem

    From the very first I day came across Dr Igudia CZcams channel, I knew that was going to be the end of my Diabetes. And to my surprise his herbs actually cured my Diabetes.

  • @FightBackAgainstDiabetes

    *You Did Not Choose To Be Classified As Diabetic, But You Can Choose To Fight Back Against Diabetes* 💪

  • @goodmail0yahoo
    @goodmail0yahoo Před rokem

    healthy kindy longer life! healty liver color life!

  • @gojuryu3
    @gojuryu3 Před rokem

    thank you.

  • @thongxaychanvisouth432

    thank from Laos

  • @torrpaxmanorpaton5873

    ♥w♥o♥w♥!! Crush your competition with 'Promo sm'!!

  • @ahmedahm1
    @ahmedahm1 Před rokem

    Fantastic talk ! Thank you for posting & sharing the knowledge !

  • @stephenbamgbose2310

    Thank you for never letting me down doc. being recommended to doctor Igudia on CZcams has being a great blessing to my family his cure for Type 2 diabetes is a genuine one thanks for your good deed toward humanity

  • @stephenbamgbose2310

    Thank you for never letting me down doc. being recommended to doctor Igudia on CZcams has being a great blessing to my family his cure for diabetes is a genuine one thanks for your good deed toward humanity

  • @stephenbamgbose2310

    Thank you for never letting me down doc. being recommended to doctor Igudia on CZcams has being a great blessing to my family his cure for diabetes is a genuine one thanks for your good deed toward humanity

  • @FolakeBamigboye
    @FolakeBamigboye Před rokem

    Times used to be very Challenging, I had the worst days of my life living with Diabetes, I appreciate you so much Dr Igudia, You have restored me my life that was lost already . Thank you so much for curing me of my diabetes with your natural Herbs 😊

  • @lucsob1964
    @lucsob1964 Před rokem

    The sound is not good

  • @dianaskolaite2277
    @dianaskolaite2277 Před rokem

    Good evening, what vitamins I can use with Ign?

  • @ahmedahm1
    @ahmedahm1 Před rokem

    23:00 Very Low Screenings in pts with DM & HTN

  • @ahmedahm1
    @ahmedahm1 Před rokem

    49:00 very interesting ! Thank you